Drug Type Small molecule drug |
Synonyms PIPC, Piperacillin, Piperacillin anhydrous + [9] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (22 May 1979), |
Regulation- |
Molecular FormulaC23H27N5NaO7S |
InChIKeyHKKJNUJNRAREQR-IDYPWDAWSA-N |
CAS Registry59703-84-3 |
Start Date01 Mar 2024 |
Sponsor / Collaborator |
Start Date01 Jan 2024 |
Sponsor / Collaborator |
Start Date30 Sep 2023 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00466 | Piperacillin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infectious Diseases | Japan | 22 Dec 2003 | |
Bacterial Infections | Japan | 22 May 1979 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | 386 | (AKI group) | noeqfvpggt(sbxypilvoc) = llwficcfhl mlzvywzmea (exspvocgui ) | Negative | 05 Nov 2019 | ||
(Non-AKI group) | noeqfvpggt(sbxypilvoc) = nsqrjsyqfo mlzvywzmea (exspvocgui ) | ||||||
Not Applicable | - | 48 | mjwnlqzgzi(sbwwqqwnbo): OR = 21.9, P-Value = < 0.008 | Positive | 08 Nov 2011 | ||
(CRRT) |